Delta 9 Cannabis Inc.
DLTNF · OTC
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Revenue | $16,490 | $17,475 | $18,436 | $18,252 |
| % Growth | -5.6% | -5.2% | 1% | – |
| Cost of Goods Sold | $12,032 | $18,994 | $15,713 | $14,621 |
| Gross Profit | $4,458 | -$1,520 | $2,724 | $3,631 |
| % Margin | 27% | -8.7% | 14.8% | 19.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $4,477 | $2,923 | $4,129 | $3,869 |
| SG&A Expenses | $4,674 | $3,085 | $4,291 | $4,016 |
| Sales & Mktg Exp. | $196 | $162 | $161 | $146 |
| Other Operating Expenses | $2,743 | $454 | $97 | $3,077 |
| Operating Expenses | $7,417 | $3,932 | $7,207 | $7,131 |
| Operating Income | -$2,959 | -$5,452 | -$4,484 | -$3,500 |
| % Margin | -17.9% | -31.2% | -24.3% | -19.2% |
| Other Income/Exp. Net | -$1,955 | -$1,768 | -$905 | $1,460 |
| Pre-Tax Income | -$4,914 | -$6,065 | -$5,388 | -$2,040 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$5,070 | -$6,230 | -$5,475 | -$2,823 |
| % Margin | -30.7% | -35.6% | -29.7% | -15.5% |
| EPS | -0.022 | -0.029 | -0.03 | -0.016 |
| % Growth | 24.3% | 2.7% | -85.2% | – |
| EPS Diluted | -0.022 | -0.029 | -0.03 | -0.016 |
| Weighted Avg Shares Out | 229,266 | 213,167 | 182,509 | 173,746 |
| Weighted Avg Shares Out Dil | 229,256 | 213,167 | 182,509 | 173,746 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3 | $10 | $0 | $0 |
| Interest Expense | $1,641 | $2,004 | $1,564 | $1,560 |
| Depreciation & Amortization | $2,083 | $2,106 | $2,145 | $2,173 |
| EBITDA | -$1,191 | -$1,911 | -$2,339 | -$1,327 |
| % Margin | -7.2% | -10.9% | -12.7% | -7.3% |